This longitudinal prospective non-clinical study, now in its 31st year,
continues to evaluate the effects of alcohol and other prenatal factors on
offspring development from birth through adulthood. Throughout those 31
years we have been studying one single sample of Seattle-born offspring,
first "observed" via maternal interview in utero, who were examined or
measured eight times in childhood and four times since then, and are now
being interviewed again as they turn about 30.
The study is the longest-lived of a set of similar studies launched at
about the same time that together have had a substantial impact on
community mental health. By demonstrating central nervous system effects
of prenatal alcohol exposure independent of physical manifestations, data
from these studies helped expand the initially limited conceptualization
of damage from a formal syndrome (Fetal Alcohol Syndrome, FAS) to include
Fetal Alcohol Effects (FAE) and Alcohol Related Neurobehavioral Disorder
(ARND) -- categories independent of facial features or details of
cognitive damage -- and, nowadays, to underpin the even more useful
umbrella concept of Fetal Alcohol Spectrum Disorders (FASD). In extensive
analyses of grouped data, our study consistently shows some effects of
prenatal alcohol exposure, such as poor vigilance/attention or poor
"executive function" (understanding and management of one's own behavior),
that are due neither to biases in clinical samples nor to the other social
pathologies that confound heavy alcohol use among pregnant women in all
studies begun later than ours. The single most cited estimate of the
incidence rate of FASD, nine per thousand births, comes from our analysis
of the first seven years of the life of these subjects. Recent findings
include a substantial impact of prenatal alcohol exposure independent of
these other factors on alcohol problems in the 21-year-old and equally
substantial and covariate-free impacts on the profile of psychiatric
disorders at age 25.
Click here
for a list of selected publications.
Neuroanatomic/Neuropsychologic
Analyses
of FAS/FAE Deficits
Principal Investigator: Ann
Streissguth
Funded by the
National Institute on
Alcohol Abuse & Alcoholism (NIAAA)
This research proposed to quantify and link the neuroanatomic and
neuropsychological abnormalities in people with brain damage caused by
prenatal alcohol exposure. Prior to this study, there were few methods for
quantifying the brain damage caused by alcohol and its relation to
dysfunctional behavior in the individual patient, and none that used
modern morphometric methods measuring neuroanatomic shape variation as
discernible from MRI scans. Traditionally the only "quantification" of
this brain damage was indirect, and lies in the diagnostic category called
Fetal Alcohol Syndrome (FAS). Unfortunately, FAS is a very insensitive
guide to the extent of underlying brain pathology, even though it is
specific for alcohol. People with FAS vary widely in many channels of
behavior, and many other heavily exposed people who do not meet criteria
for an FAS diagnosis show neurobehavioral deficits that may be as severe
as FAS. Such patients are often referred to as having Fetal Alcohol
Effects (FAE) or Alcohol Related Neurodevelopmental Disorders (ARND).
Although we hypothesized that our image analysis methods would reveal
significant mean differences in brain form between FAS/FAE and Controls,
we were surprised to find that the most significant finding was a
hypervariation of form of the Corpus Callosum (CC: a white matter pathway
connecting the two hemispheres of the brain). Subjects with FAS and FAE
had callosa that were generally thicker or thinner than control
counterparts. In addition 3, of the subjects with FAS/FAE showed frank
dysgenesis (incomplete development) of the corpus callosum. This study
also found that there was a complete intermingling of (lack of
discrimination between) the alcohol exposed subjects with and without the
facial features of FAS in terms of representations of the shape of the CC.
There was no difference in CC neuroanatomy between subjects with FAS and
those with FAE or ARND.
When the shape measurement of the Corpus Callosum was combined with
results of neuropsychological testing, we found further surprising
results. The variation in the shape of the corpus callosum was related to
two specific patterns of neuropsychological performance. Those subjects
with FAS/FAE whose callosa were thinner than controls demonstrated
deficits in motor coordination but had relatively normal executive
function abilities. Conversely, those subjects with FAS/FAE whose callosa
were thicker than controls demonstrated relatively normal motor
coordination but had deficits in executive function abilities. Utilizing
neuroanatomy and neuropsychology together, we could discriminate between
FAS/FAE subjects and control subjects; with 100% sensitivity and 93%
specificity. Again the two exposed groups were completely intermingled
demonstrating that there is no difference in neuroanatomy and
neuropsychology between subjects diagnosed FAS and those with FAE or ARND.
Future research will use the same methodology to study other brain regions
thought to be associated with the damaging effects of prenatal alcohol
exposure.
The potential role of these findings suggests that MRI screening of
extent of damage in FAS/FAE would be of great benefit. For those without
the full stigmata of the disorder, but with characteristic dysfunctional
behaviors, the detection of neuroanatomic anomalies may permit proper
identification and service delivery prior to the development of
debilitating secondary consequences. Also, it will become possible to draw
much finer distinctions among the clinical samples currently diagnosed as
"FAS" or "FAE". Prognoses would thereby become more accurate, and the
provision of therapeutic intervention or special education would become
both more effective and more humane. Further work is appropriate in order
to extend these correlated dimensions of structural-functional deficit
downward into childhood or even infancy.
The Center on Human
Development and Disability's
summary
of Ann Streissguth's brain study.
Click here
for a list of selected publications.
Functional MRI of FAS/FAE
Principal Investigator: Paul Connor
Funded by the
National Institute on
Alcohol Abuse & Alcoholism (NIAAA)
Building on the work of our neuroanatomy and neuropsychology study, we
have recently begun work on a study of functional MRI (fMRI) in
individuals with FAS/FAE. This study proposes to demonstrate abnormalities
in the functional activity of the brain due to prenatal alcohol exposure.
Subjects with FAS, FAE, and matched controls will be administered a series
of neuropsychological tests spanning the functions of mathematics,
attention, motor coordination, and executive function while a special type
of MRI is being conducted. Functional MRI (fMRI) measures local variations
in the ratio between oxygenated and deoxygenated blood. When a region of
the brain is more active, there is a localized imbalance in this ratio.
Therefore, by performing neuropsychological tasks while images are being
acquired, we can establish the locations within the brain and the amount
of activation that each subject requires in order to complete the task.
These activation maps can then be compared between patients with FAS/FAE
and their control counterparts in order to elucidate differences in
activation.
We hypothesize that there will be a difference between exposed patients
and controls on the pattern and extent of activation of brain regions
during these neuropsychological tasks. We also hypothesize that, like much
of our previous work, there will be no significant differences between FAS
and FAE subjects in their patterns of activation.
With the development of fMRI techniques, we now have the opportunity to
assess directly the metabolic activity in the brains of subjects who have
been exposed to alcohol prenatally and to determine the differences in
that activity from healthy controls. Through the use of these techniques,
we will be able to add to our understanding of the pathways of prenatal
alcohol effects on the brain. In the future, the techniques utilized in
this study could aid in early identification and diagnosis, quantification
of the level or subtype of deficit, and suggestions for appropriate
treatment approaches that could be attempted for patients with prenatal
alcohol exposure.
Click here
for a list of selected publications.
Parent-Child
Assistance
Program (PCAP)
Principal Investigator: Therese Grant
Funded by Washington State Legislature
(Division of Alcohol and Substance
Abuse);
originally funded by Center for Substance Abuse Prevention (CSAP)
The Parent-Child Assistance Program (PCAP), originally known as the
Seattle Birth to 3 Project, began in 1991 as a 5-year federally funded
research demonstration project designed to test the efficacy of a model of
intensive, long-term paraprofessional advocacy with high-risk mothers who
abuse alcohol or drugs heavily during pregnancy and are estranged from
community service providers. The primary goal of the program is a
straightforward one -- to prevent alcohol and drug exposure among the
future children of these mothers. In 1996, on the basis of demonstrated
positive outcomes, the Washington State Legislature appropriated funds for
continuation of the Seattle program and expansion to a Tacoma site; in
1999 sites in Yakima and Spokane (including Grant County) were funded,
creating a capacity to serve 360 families. In 2005 and 2006, sites in
Cowlitz and Skagit Counties were funded, increasing that capacity to 540.
The program has been recognized by SAMHSA's National Registry of Effective
Programs and Practices, and has been commended by Drug Strategies, a
Washington D.C.-based policy research institute. The model has been
replicated at over a dozen sites in the United States and Canada.
PCAP paraprofessional advocate case managers work with a caseload of
approximately 15 families each, for 3 years beginning at enrollment during
pregnancy or in the postpartum period. PCAP does not provide direct
treatment services. Instead, advocates help substance-abusing mothers
address a wide range of environmental problems, connect mothers and their
families with existing community services, coordinate services among this
multidisciplinary network, assist mothers in following through with
provider recommendations (including obtaining substance abuse treatment
and staying in recovery), and assure that the children are in safe home
environments and receiving appropriate health care. A unique feature of
the model is that women are never asked to leave the program because of
relapse or setbacks.
The lives of mothers enrolled in PCAP are characterized by poverty,
upbringing by substance-abusing parents, childhood abuse, abusive adult
relationships, trouble with the law, and chaotic and unstable living
conditions. As products of this background they are often distrustful of
community service agencies. PCAP paraprofessional advocates have
themselves overcome many difficult life circumstances prior to achieving
successes in school, jobs, and parenting. Because of this, the advocates
are able to inspire trust and hope, and act as realistic role models and
guides toward meaningful change.
Notably, there has been relatively low staff turnover in a field known
for high rates of burnout. Three administrative components contribute to
job satisfaction and retention: weekly group staffing, individual weekly
supervision by a master's level supervisor, and a dynamic evaluation
process allowing advocates to see that they are indeed helping clients
make gains, as well as to observe areas for improvement.
The effectiveness of PCAP has been demonstrated. Among 156 PCAP mothers
recently exiting the program: 88% completed alcohol/drug treatment; 47%
had been abstinent from alcohol/drugs for more than 6 months at program
exit, and 89% had more than 6 months abstinence from alcohol/drugs while
in the program; 73% were using a contraceptive method on a regular basis,
and 51% were using a more reliable method; 25% delivered a subsequent
child, and of these 41% were clean and sober throughout the pregnancy,
and another 37% quit using alcohol and drugs after pregnancy recognition.
A study of 45 original PCAP clients followed-up an average of 2.5 years
after graduation indicated that benefits of the program were sustained.
The proportion of clients abstinent from alcohol and drugs for at least 6
months at the time of interview increased significantly from 31% at
graduation to 51% at follow-up. Those abstinent for at least one year
increased from 38% to 48%. Subsequent births decreased from 27% during the
program to 9% during the follow-up period.
"This program really helped me think about my life. They showed
me the right direction. They showed me that I am responsible. That no
matter who I am or what I do, I am somebody. It is never too
late."
-PCAP Client
Click
here for a brochure (in pdf
format) describing PCAP services, eligibility, and referral
information.
For information regarding PCAP evaluation forms, please contact our
office at (206) 543-7155.
Click here for a list of
selected publications.
Prevention of Methamphetamine Abuse: A
Pilot Intervention with Drug-Endangered
Children and Their Mothers
Principal Investigator: Therese Grant, Ph.D.
Funded by the Center
for Substance Abuse Prevention (CSAP),
a division of the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
Two University of Washington programs-the evidence-based Parent-Child
Assistance Program (PCAP) and the Center on Infant Mental Health and
Development (CIMHD)- have partnered to pilot an innovative
infant/mother mental health intervention.
PCAP is a home visitation intervention that has worked since 1991
with high-risk mothers who abuse alcohol or drugs during pregnancy,
and their children. The model has been designated by the National
Registry of Evidence-based Programs and Practices (NREPP) as a
Promising Practice. For many years we have seen the need to introduce
a more child-focused intervention component to our PCAP model. At the
same time we have seen a dramatic increase in the number of mothers
in the Washington State PCAP who use amphetamine/methamphetamines
during pregnancy (from 0% in 1991 to 55% currently). We have an
exciting opportunity to address both of these concerns now. CIMHD is
the only university-affiliated center of its kind in the country
combining education, research, clinical services and policy
leadership. Together we are conducting a pilot project in which we
supplement the standard 3-year PCAP intervention
with a nested 12-month infant/mother mental health intervention
delivered in the home by CIMHD-supervised infant mental health
therapists. We will evaluate the pilot by comparing outcomes from the
enhanced infant/mother intervention group (N=40 infant/mother pairs)
with data from a matched comparison group (N=40 infant/mother pairs)
that receives standard PCAP intervention alone.
We hypothesize that compared to standard PCAP, mothers in the
intervention group will demonstrate improved responsiveness to the
child and greater improvement in quality of infant/mother
interaction, and that improved relationships will yield reduced rates
of maternal drug/alcohol use, higher rates of permanent maternal
child custody placement, improved rates of safe, stable housing, and
fewer additional methamphetamine and other substance-exposed
pregnancies. For infants in the intervention group, we hypothesize
increased reciprocity in interaction with the mother, decreased
indicators of disordered relationship, and improved age-specific mental
and motor development and functional social-emotional
competence. This project will maximize prevention efforts by
targeting limited resources to methamphetamine-affected mothers and
children at highest risk for compromised outcomes.
Principal Investigator: Eric Schapper, UW School of Law
Co-Investigator: Ann Streissguth
Project Director: Kay Kelly
Funded by the
Robert Wood Johnson
Foundation
A collaboration between the School of Law and the School of Medicine
has been formed with the awarding of a Robert Wood Johnson Foundation
Public Policy Grant to establish an FAS/FAE Legal Issues Resource Center.
The Center will operate out of the Fetal Alcohol and Drug Unit in the
Department of Psychiatry and Behavioral Sciences.
The one year grant began January 15, 2003 and is designed to identify
and seek to improve public policies that affect individuals with Fetal
Alcohol Syndrome or Fetal Alcohol Effects. The Center will provide to
those individuals, their families, their advocates, and their communities
information regarding legal rights that have an important impact on
individuals with FAS/FAE, including educational, disability, criminal and
juvenile justice issues. This information will be publicly available
through the website of the Fetal Alcohol and Drug Unit.
We will respond by telephone, website referral and email to requests
for assistance from families of those with FAS/FAE, as well as from
advocates, attorneys, law enforcement, judges, corrections and probation
officers. We are dedicated to providing assistance to those who have
Civil Justice and Resource Issues such as rights under the Individuals
With Disabilities Education Act (IDEA), benefits under the Social Security
Act (SSI and Title II) and eligibility for state programs for the
developmentally disabled. We will also address Criminal and Juvenile
Justice Issues such as FAS/FAE and sentencing, juvenile court and
correctional facilities practices.
Since this disability is largely unknown to the court family, we plan
to organize peer training about FAS/FAE for Judges, Defense Attorneys,
Prosecutors, Probation and Correctional Officers. Police Officers play a
vital role as the initial point of contact for those with FAS/FAE and the
criminal and juvenile justice systems. Sensitizing police officers to
the disability is critical. We also want to publish articles on FAS/FAE
in professional journals (for judges as well as attorneys specializing in
education, disability or Social Security law) focusing on the relevance of
FAS/FAE to each particular specialty.
The website will include a basic overview of each FAS/FAE issue, a list
of relevant cases, documents that we think will be helpful to families,
advocates and professionals and a list of books that address the several
problems we have outlined. We want to identify the best practices and
strategies for dealing with the legal issues and then disseminate this
through the website. Of course, the website material will expand over the
years time.
In order to identify the public policies which have the greatest impact
on those with FAS/FAE, we hope to hear from individuals with the
disability, their families and advocates as well as the various
professionals regarding specific problems with which the FAS/FAE Legal
Issues Resource Center can be helpful.
Click
here for a list of selected publications.
Indian Health
Service (IHS) FASD Project
Principal Investigator: Therese Grant, Ph.D.
Funded by the Indian Health Service
(IHS)
Since 1983, the Indian Health Service has
funded the Fetal Alcohol & Drug
Unit to provide information and strategies for prevention and
intervention
to American Indian/Alaska Native (AI/AN) communities. This contract
enables the unit to carry out the following activities each year:
Provide consultations to American Indian/Alaska Native (AI/AN)
individuals with Fetal Alcohol Spectrum Disorders (FASD) and their
families as well as referrals for FASD evaluation and diagnosis.
Consultations may include referrals to the FAS Diagnostic and Prevention
Network (FASDPN) for diagnosis of minors, and to professionals in the
health, school, legal, social services systems, and to other service
providers as appropriate.
Provide technical support on FASD issues to service providers and
students working with AI/AN populations as requested. This support will be
provided through phone and in person conferences with service providers,
and research/clinical internships. Technical support will be provided to
AI/AN groups as requested, in developing and funding FAS screening,
prevention and intervention programs.
Conduct one 3-day training workshop at the UW Fetal Alcohol and Drug
Unit for 6-8 service providers. Training will include (1) didactic
overview of FASD and secondary disabilities, working with young children
and families, special topics (mental health issues, criminal justice,
sexual deviance); (2) Parent Child Assistance Program (PCAP) site visit
and orientation to evidence-based practices for FASD prevention and
intervention with high-risk mothers; and (3) FAS Diagnostic and Prevention
Network (FASDPN) site visit and training on diagnosis, family interviews
and feedback, clinic and research coordination.
Conduct at least one onsite FASD workshop at a site to be agreed
upon by the project officer. Training topics will include: general FASD
overview, screening, prevention and intervention, psychosocial issues
across the lifespan, special issues with AI/AN populations, forensics.
Work with the Northwest Portland Area Indian Health Board on FASD
issues as requested.
Respond to requests for information on FASD and related topics by
providing written information, resources and referrals, and by responding
to requests for talks, workshops, and presentations.
Summarize existing unidentified, aggregate FADU research data
involving AI/AN participants, and report on recommended strategies for
FASD prevention.
Click here
for link to list of selected publications